Axel Bolte
About Axel Bolte
Axel Bolte is a co-founder of Inozyme Pharma and has extensive experience in the life sciences sector, including roles as CEO and Director at various companies. He holds degrees in Biochemistry and Economics and has a background in private equity and investment advisory.
Work at Inozyme
Axel Bolte co-founded Inozyme Pharma in 2015, a company dedicated to developing treatments for severe metabolic diseases that currently lack effective therapies. He served as Chief Executive Officer until March 2023 and continues to contribute as a co-founder. Inozyme Pharma operates with a focus on innovative solutions in the life sciences sector.
Education and Expertise
Axel Bolte holds a degree in Biochemistry from ETH Zürich, where he studied from 1991 to 1996. He also earned an MBA in Economics from the University of St. Gallen between 1998 and 2000. Additionally, he studied Organic Chemistry at the University of Cambridge for one year in 1994-1995. His educational background supports his strong operational and investment expertise in the life sciences.
Background
Axel Bolte has extensive experience in the life sciences and investment sectors. He worked as an Investment Advisor at HBM Partners AG from 2003 to 2017 and later served as a Venture Partner at the same firm until 2019. He held the position of Director at IVERIC bio from 2019 to 2023 and has been involved with various companies as a board member and director, including Allena Pharmaceuticals, Nabriva Therapeutics, and PTC Therapeutics.
Achievements
Throughout his career, Axel Bolte has demonstrated a strong track record in both operational roles and private equity. He has been involved in healthcare investments globally, achieving notable returns. His leadership at Inozyme Pharma and previous roles at various firms highlight his commitment to advancing treatments in the life sciences. He has also served on the board of directors for multiple healthcare companies.
Current Roles
In addition to his role at Inozyme Pharma, Axel Bolte serves as a Director at Burka Coffee Estates Ltd. and Mondul Coffee Estates Ltd. since 2003. He is also a managing member of Healthcare Advisors GmbH since March 2017. His involvement in these companies reflects his diverse interests and ongoing commitment to both the life sciences and agricultural sectors.